FDA Panel Recommends to Redesign COVID-19 Vaccines to Fight ‘Omicron’ Variants this Fall
FDA Panel Recommends to Redesign COVID-19 Vaccines to Fight ‘Omicron’ Variants this Fall “If it ain’t broke, don’t fix it.” The Food and Drug Administration’s advisory committee voted on Tuesday to change the strain composition of COVID-19 vaccines as immunity continues to wane and more people suffer from adverse reactions from the experimental shots. FDA’s…